# An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis

> **NCT00207714** · PHASE2 · COMPLETED · sponsor: **Centocor, Inc.** · enrollment: 172 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Golimumab
- **DRUG:** MTX
- **DRUG:** Placebo
- **DRUG:** Infliximab

## Key facts

- **NCT ID:** NCT00207714
- **Lead sponsor:** Centocor, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** 2005-02
- **Final completion:** 2006-02
- **Target enrollment:** 172 (ACTUAL)
- **Last updated:** 2012-10-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00207714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00207714, "An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT00207714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*